These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33359639)

  • 1. Post-stroke depression: Chaos to exposition.
    Sarkar A; Sarmah D; Datta A; Kaur H; Jagtap P; Raut S; Shah B; Singh U; Baidya F; Bohra M; Kalia K; Borah A; Wang X; Dave KR; Yavagal DR; Bhattacharya P
    Brain Res Bull; 2021 Mar; 168():74-88. PubMed ID: 33359639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The psychopharmacology of brain vascular disease/poststroke depression.
    Jones M; Corcoran A; Jorge RE
    Handb Clin Neurol; 2019; 165():229-241. PubMed ID: 31727214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-stroke depression: Mechanisms and pharmacological treatment.
    Villa RF; Ferrari F; Moretti A
    Pharmacol Ther; 2018 Apr; 184():131-144. PubMed ID: 29128343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in antidepressants for treating post-stroke depression.
    Paolucci S
    Expert Opin Pharmacother; 2017 Jul; 18(10):1011-1017. PubMed ID: 28535081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
    Legg LA; Tilney R; Hsieh CF; Wu S; Lundström E; Rudberg AS; Kutlubaev MA; Dennis M; Soleimani B; Barugh A; Hackett ML; Hankey GJ; Mead GE
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31769878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-stroke depression: an update.
    Espárrago Llorca G; Castilla-Guerra L; Fernández Moreno MC; Ruiz Doblado S; Jiménez Hernández MD
    Neurologia; 2015; 30(1):23-31. PubMed ID: 22901370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stroke and depression].
    Sivolap YP; Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9):143-147. PubMed ID: 31626232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance and possibilities of therapy of post-stroke depression].
    Trusova NA; Levin OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9. Vyp. 2):60-67. PubMed ID: 31825392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Chinese Classical Prescription Chaihu Shugan Powder in Treatment of Post-Stroke Depression: An Overview.
    Gao Z; Wang Y; Yu H
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Post-Stroke Depression.
    Starkstein SE; Hayhow BD
    Curr Treat Options Neurol; 2019 Jun; 21(7):31. PubMed ID: 31236751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD.
    Thorkelson G; Bielefeldt K; Szigethy E
    Inflamm Bowel Dis; 2016 Jun; 22(6):1509-22. PubMed ID: 27167571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of selective serotonin reuptake inhibitors versus tricyclic antidepressants on cerebrovascular events: a nationwide population-based cohort study.
    Lee YC; Lin CH; Lin MS; Lin JW; Chang CH; Lai MS
    J Clin Psychopharmacol; 2013 Dec; 33(6):782-9. PubMed ID: 24091857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive overview of post-stroke depression treatment options.
    Raggi A; Serretti A; Ferri R
    Int Clin Psychopharmacol; 2024 May; 39(3):127-138. PubMed ID: 38170802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tricyclic Antidepressants and Monoamine Oxidase Inhibitors: Are They Too Old for a New Look?
    Chockalingam R; Gott BM; Conway CR
    Handb Exp Pharmacol; 2019; 250():37-48. PubMed ID: 30105472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of cognitive impairment between medicated and medication-free patients with remitted major depression: class-specific influence by tricyclic antidepressants and newer antidepressants.
    Nagane A; Baba H; Nakano Y; Maeshima H; Hukatsu M; Ozawa K; Suzuki T; Arai H
    Psychiatry Res; 2014 Aug; 218(1-2):101-5. PubMed ID: 24768252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of tricyclic antidepressants and selective serotonin re-uptake inhibitors on handwriting movements of patients with depression.
    Tucha O; Aschenbrenner S; Eichhammer P; Putzhammer A; Sartor H; Klein HE; Lange KW
    Psychopharmacology (Berl); 2002 Jan; 159(2):211-5. PubMed ID: 11862351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
    Pollok J; van Agteren JE; Carson-Chahhoud KV
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant drugs: does it matter if they inhibit the reuptake of noradrenaline or serotonin?
    Eriksson E
    Acta Psychiatr Scand Suppl; 2000; 402():12-7. PubMed ID: 10901154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-hospital predictors of post-stroke depression for targeted initiation of Selective Serotonin Reuptake Inhibitors (SSRIs).
    Yi J; Lu J; Yang A; Marsh EB
    BMC Psychiatry; 2022 Nov; 22(1):722. PubMed ID: 36402974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tricyclic antidepressants and selective serotonin reuptake inhibitors but not anticonvulsants ameliorate pain, anxiety, and depression symptoms in an animal model of central post-stroke pain.
    Shyu BC; He AB; Yu YH; Huang ACW
    Mol Pain; 2021; 17():17448069211063351. PubMed ID: 34903115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.